Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Abdullahi Bello Umar · Sankore

Ahmadu Bello University

Abdullahi Bello Umar

Name matching only

This profile was assembled from author names on publications. Open indexes routinely split one researcher across several such profiles, so these totals may be incomplete.

Publications

56

Citations

509

h-index

14

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

19

Works published 2022 onward have been swept for this country. Figures are complete within that window, to the extent the open indexes are.

Affiliations

Every institution this scholar has appeared with on a work, by how many.

Ahmadu Bello University56 works
Bayero University Kano4 works
Abdullahi Fodio University of Science and Technology1 works

Publications

56 works in the graph, newest first.

Computational design and evaluation of anilinoquinazoline derivatives as potential anti-tuberculosis agents: DFT, docking, ADMET, and molecular dynamics simulation
2026The MicrobeJournalOpen access2 citations10.1016/j.microb.2026.100683
In silico–guided design of 2-methylchroman-3-yl formate derivatives targeting PanC as potential anti-tuberculosis agents
2026Letters in Drug Design & DiscoveryJournalOpen accessSenior author0 citations10.1016/j.lddd.2026.100404
Kernel Naïve Bayes QSAR models for discriminating thyroid hormone receptor agonists and non-agonists among hydroxylated polychlorinated biphenyls
2026Zenodo (CERN European Organization for Nuclear Research)JournalOpen access0 citations10.5281/zenodo.20129139
Kernel Naïve Bayes QSAR models for discriminating thyroid hormone receptor agonists and non-agonists among hydroxylated polychlorinated biphenyls
2026Zenodo (CERN European Organization for Nuclear Research)JournalOpen access0 citations

10.5281/zenodo.20129138

Computational design and optimization of INHA inhibitors based on 5-amino-1 H-pyrazole-4-carbonitrile for anti-tuberculosis applications

2026Discover Chemistry.JournalOpen accessSenior author0 citations10.1007/s44371-026-00706-5

Classification of hydroxylated polychlorinated biphenyls as thyroid hormone receptor agonists and non-agonists using support vector machine–based QSAR models

2026Zenodo (CERN European Organization for Nuclear Research)JournalOpen access0 citations10.5281/zenodo.20133512

Classification of hydroxylated polychlorinated biphenyls as thyroid hormone receptor agonists and non-agonists using support vector machine–based QSAR models

2026Zenodo (CERN European Organization for Nuclear Research)JournalOpen access0 citations10.5281/zenodo.20133511

Design and Construction of a Room Air Purifier for Clean Domestic Ventilation

2026JournalOpen accessFirst author0 citations10.70315/uloap.ulphy.2026.0101006

Design of benzofuro [3,2-d] pyrimidine-based MmpL3 inhibitors as potential anti-tuberculosis agents using integrated in silico approaches

2026In Silico PharmacologyJournalOpen accessSenior author0 citations10.1007/s40203-026-00646-z

Design and in silico optimization of pyrazolopyridine-based pantothenate synthetase (PanC) inhibitors as novel anti-tuberculosis leads

2026Current Pharmaceutical AnalysisJournalOpen accessSenior author0 citations10.1016/j.cpan.2026.05.003

Computational Fluid Dynamics (Cfd) Simulation of Phase Change Material (Pcm) As Thermal Comfort Regulator for Residential Buildings in Hot Climates

2026Zenodo (CERN European Organization for Nuclear Research)JournalOpen access0 citations10.5281/zenodo.21697888

Computational Fluid Dynamics (Cfd) Simulation of Phase Change Material (Pcm) As Thermal Comfort Regulator for Residential Buildings in Hot Climates

2026Zenodo (CERN European Organization for Nuclear Research)JournalOpen access0 citations10.5281/zenodo.21697887

Computational Fluid Dynamics (Cfd) Simulation of Phase Change Material (Pcm) As Thermal Comfort Regulator for Residential Buildings in Hot Climates

2026Zenodo (CERN European Organization for Nuclear Research)JournalOpen access0 citations10.5281/zenodo.21697530

Computational Fluid Dynamics (Cfd) Simulation of Phase Change Material (Pcm) As Thermal Comfort Regulator for Residential Buildings in Hot Climates

2026Zenodo (CERN European Organization for Nuclear Research)JournalOpen access0 citations10.5281/zenodo.21697531

Investigating the potential of novel antioxidant flavonoids: a comprehensive study of drug-likeness, molecular docking, pharmacokinetics, and DFT analysis

2025Future Journal of Pharmaceutical SciencesJournalOpen accessSenior author9 citations10.1186/s43094-025-00837-z

In silico exploration of novel EGFR-targeting compounds: integrative molecular modeling, docking, pharmacokinetics, and MD simulations for advancing anti-cervical cancer therapeutics

2025Scientific ReportsJournalOpen access14 citations10.1038/s41598-025-91135-4

Computational design, pharmacokinetics, molecular docking and molecular dynamic simulation of novel anti-tubercular inhibitors

2025In Silico Research in BiomedicineJournalOpen access13 citations10.1016/j.insi.2025.100012

In silico exploration of 6-sulfonyl-8-nitrobenzothiazinone derivatives as mycobacterium tuberculosis GyrB inhibitors: Molecular docking, md simulation, DFT, and pharmacokinetic studies

2025In Silico Research in BiomedicineJournalOpen access11 citations10.1016/j.insi.2025.100018

Computational design and evaluation of hydrantoin derivatives as potential anti-tubercular agents: Insight from ADMET, molecular docking, DFT, and molecular dynamic simulations

2025Letters in Drug Design & DiscoveryJournalOpen access7 citations10.1016/j.lddd.2025.100155

In Silico design and evaluation of novel anti-tubercular agents as Inha inhibitors through a virtual screening approach

2025Discover Chemistry.JournalOpen access4 citations10.1007/s44371-025-00367-w

In silico design of potent inhibitors targeting TNF-alpha, IL-1β, and TGF-β of inflammatory disease using QSAR, docking, MD simulation, ADMET, and DFT studies

2025Letters in Drug Design & DiscoveryJournalOpen access2 citations10.1016/j.lddd.2025.100203

Molecular design, ADMET evaluation, and molecular dynamic simulation of some potent sulfonamide-based compounds as anti-tuberculosis agents

2025In Silico Research in BiomedicineJournalOpen access2 citations10.1016/j.insi.2025.100035

Identification of potential anti-tubercular inhibitors through virtual screening, DFT, and molecular dynamics simulation studies

2025Current Pharmaceutical AnalysisJournalOpen access2 citations10.1016/j.cpan.2025.11.001

Design and evaluation of novel N-Aryl oxamic acid derivatives as potential anti-tubercular inhibitors: A comprehensive molecular modeling study

2025Letters in Drug Design & DiscoveryJournalOpen access1 citations10.1016/j.lddd.2025.100234

In-silico analysis and design of quinoline-based hybrids with oxadiazole and triazole frameworks as anti-diabetic agents

2025Scientific AfricanJournalOpen access1 citations10.1016/j.sciaf.2025.e02631

Structure-based Virtual Screening, and Design of Some Lead Compounds as Inhibitors of Kras-G12D of Pancreatic Cancer

2025Indonesian Journal of Cancer ChemopreventionJournalOpen access0 citations10.14499/indonesianjcanchemoprev15iss2pp108-126

Computer-aided design process of possible antisickling agents using molecular docking, pharmacokinetic assessment, homology modeling, and molecular dynamic studies targeting Hba protein

2025In Silico PharmacologyJournalOpen access0 citations10.1007/s40203-025-00424-3

Design and evaluation of novel 1-(5-Isoquinolinesulfonyl) piperazine derivatives as potential Mycobacterium tuberculosis IMPDH Inhibitors: A comprehensive molecular modelling study

2025Scientific AfricanJournalOpen access0 citations10.1016/j.sciaf.2025.e03043

Cheminformatic evaluation of the multi-protein binding potential of some diselenide derivatives: A plausible drug discovery approach for leishmaniasis

2024Discover Chemistry.JournalOpen access16 citations10.1007/s44371-024-00026-6

Exploring the potential of 2-arylbenzimidazole scaffolds as novel α-amylase inhibitors: QSAR, molecular docking, simulation and pharmacokinetic studies

2024In Silico PharmacologyJournalOpen accessSenior author10 citations10.1007/s40203-024-00205-4

QSAR, molecular docking, and pharmacokinetic analysis of thiosemicarbazone-indole compounds targeting prostate cancer cells

2024Journal of Taibah University Medical SciencesJournalOpen accessSenior author6 citations10.1016/j.jtumed.2024.07.004

Design of some phthalazine molecules as novel VEGFR-2 target inhibitors through 3D-QSAR modeling, molecular docking and dynamic simulation and pharmacokinetics profiling

2024Journal of Umm Al-Qura University for Applied SciencesJournalOpen accessFirst author3 citations10.1007/s43994-024-00197-z

Potential anti-colon cancer agents: Molecular modelling, docking, pharmacokinetics studies and molecular dynamic simulations

2024Journal of Holistic Integrative PharmacyJournalOpen access2 citations10.1016/j.jhip.2024.09.003

Identification of estrogen receptor agonists among hydroxylated polychlorinated biphenyls using classification-based quantitative structure–activity relationship models

2024Current Research in ToxicologyJournalOpen accessSenior author1 citations10.1016/j.crtox.2024.100158

Molecular docking studies of some benzoxazole and benzothiazole derivatives as VEGFR-2 target inhibitors: In silico design, MD simulation, pharmacokinetics and DFT studies

2023Intelligent PharmacyJournalOpen access49 citations10.1016/j.ipha.2023.11.010

L-Arginine Grafted Chitosan as Corrosion Inhibitor for Mild Steel Protection

2023PolymersJournalOpen access30 citations10.3390/polym15020398

Pharmacokinetic profiling of quinazoline-4(3H)-one analogs as EGFR inhibitors: 3D-QSAR modeling, molecular docking studies and the design of therapeutic agents

2023Journal of Taibah University Medical SciencesJournalOpen accessSenior author20 citations10.1016/j.jtumed.2023.02.015

Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling

2023Journal of the Egyptian National Cancer InstituteJournalOpen accessSenior author19 citations10.1186/s43046-023-00182-3

2D and 3D-QSAR Modeling of 1H‑Pyrazole Derivatives as EGFR Inhibitors: Molecular Docking, and Pharmacokinetic Profiling

2023Chemistry AfricaJournalSenior author16 citations10.1007/s42250-023-00592-9

Computational design of quinoxaline molecules as VEGFR-2 inhibitors: QSAR modelling, pharmacokinetics, molecular docking, and dynamics simulation studies

2023Biocatalysis and Agricultural BiotechnologyJournal16 citations10.1016/j.bcab.2023.102787

In-silico profiling, design, molecular docking computation, and drug kinetic model evaluation of novel curcumin derivatives as potential anticancer agents

2023Journal of the Indian Chemical SocietyJournalSenior author9 citations10.1016/j.jics.2023.100979

In-silico design of some pyrazolopyridine analogs as breast cancer inhibitors: QSAR modeling, molecular docking, MD simulation, and pharmacological features profiling

2023Journal of the Indian Chemical SocietyJournal8 citations10.1016/j.jics.2023.101053

Activity prediction, structure-based drug design, molecular docking, and pharmacokinetic studies of 1,4-dihydropyridines derivatives as α-amylase inhibitors

2023Journal of Taibah University Medical SciencesJournalOpen accessSenior author8 citations10.1016/j.jtumed.2023.12.003

Modelling PIP4K2A inhibitory activity of 1,7-naphthyridine analogues using machine learning and molecular docking studies

2023RSC AdvancesJournalOpen accessSenior author11 citations10.1039/d2ra07382j

Virtual screening, pharmacokinetic, and DFT studies of anticancer compounds as potential kinase inhibitors

2023Journal of Taibah University Medical SciencesJournalOpen accessFirst authorCorresponding10 citations10.1016/j.jtumed.2023.01.013

QSAR application of natural therapeutics inhibitors against Alzheimer's disease through in-silico virtual-screening, docking-simulation, molecular dynamics, and pharmacokinetic prediction analysis

2023Intelligent PharmacyJournalOpen access7 citations10.1016/j.ipha.2023.12.004

Molecular modeling strategy to design novel anticancer agents against UACC-62 and UACC-257 melanoma cell lines

2023Egyptian Journal of Basic and Applied SciencesJournalOpen accessFirst authorCorresponding7 citations10.1080/2314808x.2022.2161037

New flavone-based arylamides as potential V600E-BRAF inhibitors: Molecular docking, DFT, and pharmacokinetic properties

2023Journal of Taibah University Medical SciencesJournalOpen accessFirst authorCorresponding7 citations10.1016/j.jtumed.2023.02.010

Investigation of Novel Imidazole Analogues with Terminal Sulphonamides as Potential V600E-BRAF Inhibitors Through Computational Approaches

2023Chemistry AfricaJournalFirst authorCorresponding3 citations10.1007/s42250-023-00687-3

In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative activity against triple negative breast cancer (MDA-MB231) cell line

2022Bulletin of the National Research Centre/Bulletin of the National Research CenterJournalOpen accessSenior author59 citations10.1186/s42269-021-00690-z

Showing 1–50 of 56

PreviousPage 1 of 2Next